Title : Molecular docking, dynamics, and pharmacology studies on bexarotene as an agonist of ligand-activated transcription factors, retinoid X receptors.

Pub. Date : 2019 Feb 11

PMID : 30746761






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The docking studies indicated bexarotene as a lead compound that can activate various RXR receptor isoforms (alpha, beta, and gamma) and has a strong binding affinity to the receptor protein than retinoic acid, which is known as a natural endogenous RXR agonist. Tretinoin retinoid X receptor alpha Homo sapiens